> Details

Calmels, Nadege; Botta, Elena; Jia, Nan; Fawcett, Heather; Nardo, Tiziana; Nakazawa, Yuka; Lanzafame, Manuela; Moriwaki, Shinichi; Sugita, Katsuo; Kubota, Masaya; Obringer, Cathy; Spitz, Marie-Aude; Stefanini, Miria; Laugel, Vincent; Orioli, Donata; Ogi, Tomoo; Lehmann, Alan Robert

Functional and clinical relevance of novel mutations in a large cohort of patients with Cockayne syndrome

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Functional and clinical relevance of novel mutations in a large cohort of patients with Cockayne syndrome
  • Contributor: Calmels, Nadege; Botta, Elena; Jia, Nan; Fawcett, Heather; Nardo, Tiziana; Nakazawa, Yuka; Lanzafame, Manuela; Moriwaki, Shinichi; Sugita, Katsuo; Kubota, Masaya; Obringer, Cathy; Spitz, Marie-Aude; Stefanini, Miria; Laugel, Vincent; Orioli, Donata; Ogi, Tomoo; Lehmann, Alan Robert
  • imprint: BMJ, 2018
  • Published in: Journal of Medical Genetics
  • Language: English
  • DOI: 10.1136/jmedgenet-2017-104877
  • ISSN: 0022-2593; 1468-6244
  • Keywords: Genetics (clinical) ; Genetics
  • Origination:
  • Footnote:
  • Description: <jats:sec><jats:title>Background</jats:title><jats:p>Cockayne syndrome (CS) is a rare, autosomal recessive multisystem disorder characterised by prenatal or postnatal growth failure, progressive neurological dysfunction, ocular and skeletal abnormalities and premature ageing. About half of the patients with symptoms diagnostic for CS show cutaneous photosensitivity and an abnormal cellular response to UV light due to mutations in either the <jats:italic>ERCC8</jats:italic>/<jats:italic>CSA</jats:italic> or <jats:italic>ERCC6</jats:italic>/<jats:italic>CSB</jats:italic> gene. Studies performed thus far have failed to delineate clear genotype-phenotype relationships. We have carried out a four-centre clinical, molecular and cellular analysis of 124 patients with CS.</jats:p></jats:sec><jats:sec><jats:title>Methods and results</jats:title><jats:p>We assigned 39 patients to the <jats:italic>ERCC8/CSA</jats:italic> and 85 to the <jats:italic>ERCC6/CSB</jats:italic> genes. Most of the genetic variants were truncations. The missense variants were distributed non-randomly with concentrations in relatively short regions of the respective proteins. Our analyses revealed several hotspots and founder mutations in <jats:italic>ERCC6/CSB.</jats:italic> Although no unequivocal genotype-phenotype relationships could be made, patients were more likely to have severe clinical features if the mutation was downstream of the PiggyBac insertion in intron 5 of <jats:italic>ERCC6/CSB</jats:italic> than if it was upstream. Also a higher proportion of severely affected patients was found with mutations in <jats:italic>ERCC6/CSB</jats:italic> than in <jats:italic>ERCC8/CSA</jats:italic>.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>By identifying &gt;70 novel homozygous or compound heterozygous genetic variants in 124 patients with CS with different disease severity and ethnic backgrounds, we considerably broaden the <jats:italic>CSA</jats:italic> and <jats:italic>CSB</jats:italic> mutation spectrum responsible for CS. Besides providing information relevant for diagnosis of and genetic counselling for this devastating disorder, this study improves the definition of the puzzling genotype-phenotype relationships in patients with CS.</jats:p></jats:sec>